Rasha Aboelhassan, Council Member at International Association for the Study of Lung Cancer, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn:
“I am grateful to OncoDaily for giving me the opportunity to explore a new experience during ESMO 2026.
It was a valuable opportunity to engage with leading experts, exchange perspectives, and share the challenges, questions, and knowledge emerging from the latest oncology research.
From a senior oncologist’s perspective, scientific progress is not only about new data and clinical trial results.
It is also about asking the right questions:
- What do these results really mean for our patients?
- How can we translate new evidence into clinical practice?
- What challenges remain in different healthcare settings?
- How can we share knowledge across generations of oncologists?
Thank you, OncoDaily, for this opportunity and for creating a platform where scientific discussions can reach a wider oncology community.
Knowledge becomes more valuable when we share it, challenge it, and translate it into better patient care.”
You can also read: OncoDaily Ambassadors at ESMO 2026: Thank You, Madrid
